Your browser is no longer supported. Please, upgrade your browser.
Settings
FLKS Flex Pharma, Inc. daily Stock Chart
FLKS [NASD]
Flex Pharma, Inc.
Index- P/E- EPS (ttm)-2.13 Insider Own48.80% Shs Outstand18.49M Perf Week8.70%
Market Cap64.72M Forward P/E- EPS next Y-2.56 Insider Trans0.00% Shs Float13.03M Perf Month-6.42%
Income-35.60M PEG- EPS next Q-0.60 Inst Own46.10% Short Float2.59% Perf Quarter5.11%
Sales1.50M P/S43.14 EPS this Y-17.10% Inst Trans-1.88% Short Ratio2.41 Perf Half Y-23.41%
Book/sh2.60 P/B1.35 EPS next Y-5.80% ROA-59.80% Target Price21.00 Perf Year-69.43%
Cash/sh2.55 P/C1.37 EPS next 5Y- ROE-64.10% 52W Range3.01 - 12.68 Perf YTD-33.71%
Dividend- P/FCF- EPS past 5Y- ROI-67.30% 52W High-72.40% Beta-
Dividend %- Quick Ratio9.60 Sales past 5Y- Gross Margin60.80% 52W Low16.28% ATR0.32
Employees30 Current Ratio9.70 Sales Q/Q200.00% Oper. Margin- RSI (14)42.46 Volatility7.68% 9.31%
OptionableYes Debt/Eq0.00 EPS Q/Q27.20% Profit Margin- Rel Volume0.48 Prev Close3.60
ShortableYes LT Debt/Eq0.00 EarningsAug 02 BMO Payout- Avg Volume140.04K Price3.50
Recom2.00 SMA20-7.49% SMA50-7.54% SMA200-21.24% Volume67,358 Change-2.78%
Oct-14-16Downgrade Cantor Fitzgerald Buy → Hold
Apr-14-15Initiated H.C. Wainwright Buy $40
Feb-23-15Initiated ROTH Capital Buy $27
Aug-03-17 07:33AM  Edited Transcript of FLKS earnings conference call or presentation 2-Aug-17 12:45pm GMT Thomson Reuters StreetEvents
Aug-02-17 10:47PM  Flex Pharma reports 2Q loss Associated Press -9.71%
07:30AM  Flex Pharma Reports Second Quarter 2017 Financial Results Business Wire
06:50AM  Investor Network: Flex Pharma, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-17 07:30AM  Flex Pharma Initiates ALS Phase 2 Trial with FLX-787 in US Business Wire
Jul-31-17 07:30AM  Flex Pharma Names William McVicar President and Chief Executive Officer Business Wire
Jul-27-17 07:00AM  Corporate News Blog - FDA Grants Fast Track Designation to Flex Pharmas FLX-787 for the Treatment of Severe Muscle Cramps Associated with ALS ACCESSWIRE
Jul-26-17 08:00AM  Today's Research Reports on Stocks to Watch: Neuralstem and Flex Pharma Accesswire -5.77%
08:00AM  Flex Pharma to Report Second Quarter 2017 Results on August 2, 2017 Business Wire
Jul-25-17 07:30AM  FDA Grants Fast Track Designation to Flex Pharmas FLX-787 for the Treatment of Severe Muscle Cramps Associated with ALS Business Wire +11.03%
Jun-05-17 04:10PM  Flex Pharma Announces Executive Leadership Transition Business Wire
Jun-02-17 08:00AM  Flex Pharmas Phase 2 Trial with FLX-787 in Charcot-Marie-Tooth Endorsed by the Inherited Neuropathies Consortium Business Wire
May-30-17 09:23AM  Flex Pharma Presenting at Upcoming Investor Conferences in June 2017 Business Wire
May-04-17 11:58AM  Edited Transcript of FLKS earnings conference call or presentation 3-May-17 12:45pm GMT Thomson Reuters StreetEvents +5.81%
May-03-17 07:26AM  Flex Pharma reports 1Q loss Associated Press
07:15AM  Flex Pharma Reports First Quarter 2017 Financial Results Business Wire
Apr-26-17 08:00AM  FDA Clears Flex Pharma's FLX-787 to Commence US Phase 2 Trial in ALS Under IND Business Wire +15.96%
Apr-19-17 08:00AM  Flex Pharma Presents Human Efficacy Data on FLX-787 at the American Academy of Neurology Annual Meeting Business Wire
Apr-05-17 08:00AM  Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development Business Wire
08:00AM  Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Mar-23-17 07:45AM  Newly-Published Study Reinforces Efficacy Of HOTSHOT® In Preventing And Treating Muscle Cramps PR Newswire
Mar-14-17 01:04PM  FLEX PHARMA, INC. Financials
Mar-09-17 09:12AM  Edited Transcript of FLKS earnings conference call or presentation 8-Mar-17 1:30pm GMT Thomson Reuters StreetEvents
09:12AM  Edited Transcript of FLKS earnings conference call or presentation 8-Mar-17 1:30pm GMT
Mar-08-17 08:30AM  Flex Pharma Inc Earnings Call scheduled for 8:30 am ET today -16.67%
07:52AM  FLEX PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:16AM  Flex Pharma reports 4Q loss Associated Press
07:16AM  Flex Pharma reports 4Q loss
07:07AM  Q4 2016 Flex Pharma Inc Earnings Release - Before Market Open
07:00AM  Flex Pharma Reports Year End 2016 Financial Results Business Wire
Mar-01-17 03:36PM  Flex Pharma to Report Fourth Quarter and Full Year 2016 Results on March 8, 2017 Business Wire
Feb-23-17 08:44AM  FLEX PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Feb-15-17 02:52PM  Champion Triathlete Finds Solution For Struggle With Muscle Cramps PR Newswire
Feb-07-17 01:31PM  Flex Pharma to Present at the BIO CEO & Investor Conference Business Wire
Jan-24-17 07:30AM  Flex Pharma Focuses on Phase 2 Clinical Programs in Severe Neurological Diseases Business Wire
Dec-20-16 12:53PM  Champion Pro Football Fullback Goes On The Offense Against Game-Changing Cramps PR Newswire
Dec-15-16 01:04PM  FLEX PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial
Dec-12-16 06:01PM  Do Hedge Funds Love Vishay Precision Group Inc (VPG)? at Insider Monkey -6.20%
Nov-21-16 06:07PM  Flex Pharma to Present at the Piper Jaffray 28th Annual Healthcare Conference Business Wire
Nov-15-16 08:03AM  FLEX PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Nov-09-16 12:00PM  Flex Pharma to Present at the Jefferies 2016 Healthcare Conference Business Wire
Nov-03-16 07:56AM  Edited Transcript of FLKS earnings conference call or presentation 2-Nov-16 12:45pm GMT -5.27%
Nov-02-16 08:45AM  Flex Pharma Inc Earnings Call scheduled for 8:45 am ET today
08:09AM  FLEX PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:46AM  Flex Pharma reports 3Q loss
07:07AM  Q3 2016 Flex Pharma Inc Earnings Release - Before Market Open
07:00AM  Flex Pharma Reports Third Quarter 2016 Financial Results Business Wire
Oct-26-16 09:00AM  Flex Pharma to Report Third Quarter 2016 Results on November 2, 2016 Business Wire
Oct-14-16 10:45AM  ETFs with exposure to Flex Pharma, Inc. : October 14, 2016 -15.90%
08:45AM  Flex Pharma downgraded by Cantor Fitzgerald
Oct-13-16 08:45AM  Flex Pharma Provies FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update Call scheduled for 8:45 am ET today -24.73%
08:02AM  FLEX PHARMA, INC. Files SEC form 8-K, Other Events
06:30AM  Flex Pharma Provides FLX-787 Nocturnal Leg Cramp Regulatory and Clinical Update Business Wire
Sep-13-16 07:30AM  Flex Pharma Initiates Phase 2 Efficacy Study in Amyotrophic Lateral Sclerosis Business Wire
Sep-01-16 08:30AM  Flex Pharma Presenting at Upcoming Investor Conferences in September 2016 Business Wire
Aug-26-16 04:12PM  FLEX PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers -7.92%
04:05PM  Flex Pharma Announces Scientific Advisory Board Appointment and Management Change Business Wire
Aug-04-16 09:13AM  Edited Transcript of FLKS earnings conference call or presentation 3-Aug-16 12:45pm GMT
Aug-03-16 08:45AM  Flex Pharma Inc Earnings Call scheduled for 8:45 am ET today +6.68%
08:09AM  FLEX PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:30AM  Flex Pharma reports 2Q loss
07:07AM  Q2 2016 Flex Pharma Inc Earnings Release - Before Market Open
07:00AM  Flex Pharma Reports Second Quarter 2016 Financial Results Business Wire
Jul-27-16 08:30AM  Flex Pharma to Report Second Quarter 2016 Results on August 3, 2016 Business Wire
Jul-26-16 08:00AM  Flex Pharma Completes Enrollment of Human Proof-of Concept Efficacy Study in Nocturnal Leg Cramps Business Wire
Jul-06-16 08:30AM  Flex Pharma to Present at the Cantor Fitzgerald Healthcare Conference Business Wire
Jun-15-16 08:00AM  Flex Pharma Initiates Phase 2 Efficacy Study in Multiple Sclerosis Business Wire
Jun-10-16 03:31PM  FLEX PHARMA, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers
03:23PM  FLEX PHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-06-16 02:26PM  Flex Pharma, Inc. :FLKS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
Jun-03-16 08:00AM  Flex Pharma Presenting at Upcoming Investor Conferences in June 2016 Business Wire
Jun-02-16 08:00AM  Scientific Breakthrough In Sports Nutrition To Change The Game For Millions Of Endurance Athletes PR Newswire
07:30AM  Flex Pharma Launches First Consumer Product Scientifically Proven to Prevent and Treat Muscle Cramps Business Wire
May-25-16 05:04PM   CEOs Make Big Buys of Their Companies Stocks
08:00AM  Flex Pharma Initiates Human Efficacy Study with Single Molecule Tablet in Nocturnal Leg Cramps Business Wire
May-17-16 08:40AM  FLEX PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
May-13-16 04:23PM  FLEX PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Of
May-04-16 08:45AM  Flex Pharma Inc Earnings Call scheduled for 8:45 am ET today
08:11AM  FLEX PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:16AM  Flex Pharma reports 1Q loss
07:07AM  Q1 2016 Flex Pharma Inc Earnings Release - Before Market Open
07:00AM  Flex Pharma Reports First Quarter 2016 Financial Results Business Wire
Apr-27-16 08:00AM  Flex Pharma to Report First Quarter 2016 Results on May 4, 2016 Business Wire
Apr-19-16 04:40PM  FLEX PHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
04:01PM  Flex Pharmas Positive Human NLC Study Selected for Presentation at AAN Annual Meeting Business Wire
Apr-06-16 08:00AM  Flex Pharma Collaborator Penn State Presents Positive Human Muscle Cramp Data Business Wire
Mar-31-16 03:59PM  FLEX PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Mar-30-16 02:52PM  5 Stocks Insiders Love Right Now at TheStreet
Mar-28-16 06:45PM  CEO of Flex Pharma Buys Nearly 50,000 Shares
Mar-27-16 10:20AM  Big Biotech Trades Dominate Recent Insider Buying: Seattle Genetics, Minerva Neurosciences, OvaScience and More at 24/7 Wall St.
Mar-18-16 07:05AM  The cult marketing plan behind one Boston biotechs pending product launch at bizjournals.com
Mar-14-16 08:15AM  Flex Pharma (FLKS) Jumps: Stock Adds 16.7% in Session +32.02%
08:00AM  Flex Pharma Positive Human NLC Study Selected for Late-Breaking Presentation at AAN Annual Meeting Business Wire
Mar-09-16 03:59PM  Edited Transcript of FLKS earnings conference call or presentation 8-Mar-16 1:30pm GMT
02:43PM  FLEX PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-08-16 08:30AM  Flex Pharma Inc Earnings Call scheduled for 8:30 am ET today
07:40AM  FLEX PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition
07:15AM  Flex Pharma reports 4Q loss
07:07AM  Q4 2015 Flex Pharma Inc Earnings Release - Before Market Open
07:00AM  Flex Pharma Reports Year End 2015 Financial Results Business Wire
Flex Pharma, Inc., a biotechnology company, develops and commercializes products for the treatment of muscle cramps and spasms associated with neurological conditions and exercise-associated muscle cramps in the United States. The company operates through two segments, Consumer Operations and Drug Development. Its lead drug candidate includes FLX-787, a single molecule, chemically synthesized, and transient receptor potential ion channel activator, which is in exploratory Phase 2 clinical trial in Australia for the treatment of patients with multiple sclerosis and amyotrophic lateral sclerosis. The company also offers HOTSHOT, a consumer beverage to prevent and treat exercise associated muscle cramps. It markets and sells its HOTSHOT product online through its e-commerce Website, as well as through third-party Websites. Flex Pharma, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Westphal Christoph HPresident and CEONov 08Buy7.317,00051,1703,941,118Nov 08 04:23 PM
Westphal Christoph HPresident and CEONov 07Buy5.708,87050,5593,934,118Nov 07 04:43 PM
McCabe John P.VP of Finance & TreasurerNov 07Buy6.011,6509,9171,650Nov 07 04:40 PM